CPCCX | RYVTX | CPCCX / RYVTX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 29 years | 20 years | - |
Gain YTD | 3.869 | -38.504 | -10% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | 250 | 1000 | 25% |
Net Assets | 7.3M | 14M | 52% |
Annual Yield % from dividends | 2.00 | 5.31 | 38% |
Returns for 1 year | 3.87 | -37.82 | -10% |
Returns for 3 years | 15.59 | -55.21 | -28% |
Returns for 5 years | 5.96 | -92.76 | -6% |
Returns for 10 years | -49.79 | -98.88 | 50% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NWXQX | 16.65 | 0.06 | +0.36% |
Nationwide Mid Cap Market Idx Instl Svc | |||
SHSCX | 50.90 | 0.11 | +0.22% |
BlackRock Health Sciences Opps Inv C | |||
SEEFX | 19.58 | 0.01 | +0.05% |
Saturna Sustainable Equity | |||
DRYQX | 20.87 | N/A | N/A |
BNY Mellon Research Growth Y | |||
NWHTX | 30.93 | -0.07 | -0.23% |
Nationwide Bailard Tech & Sci R6 |